Skip to content

Comparison of Ketamine and Etomidate During Rapid Sequence Intubation in Trauma Patients

Comparison of Effects on Hemodynamics Between Ketamine and Etomidate During Rapid Sequence Intubation in Trauma Patients With High Shock Index

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04120870
Enrollment
10
Registered
2019-10-09
Start date
2019-10-01
Completion date
2021-12-30
Last updated
2022-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shock, Traumatic, Trauma

Keywords

etomidate, ketamine, rapid sequence intubation, trauma, hemodynamics

Brief summary

In trauma patients with high shock index, the investigators compare the effects on hemodynamics between ketamine and etomidate.

Detailed description

In trauma patients, rapid sequence intubation is recommended. The drug of choice, however, has been debated. One cohort comparative study showed ketamine had benefit in hemodynamics compared to etomidate in trauma patients. One observational study showed in high shock index patients, ketamine showed maintain systolic blood pressure. And other retrospective showed less clinical hypotension was less in ketamine. However there is no randomized controlled study comparing ketamine and etomidate in trauma patients. The purpose of this study is comparing the effects of hemodynamics between ketamine and etomidate in high shock index trauma patients.

Interventions

DRUGEtomidate Injection 0.2 mg/kg

The induction agent of rapid sequence intubation is etomidate. 0.2 mg/kg

DRUGKetamine injection 2 mg/kg

The induction agent of rapid sequence intubation is ketamine. 2 mg/kg

Sponsors

Unimedics (http://unimedics.co.kr)
CollaboratorUNKNOWN
Ajou University School of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Masking description

open label

Intervention model description

ketamine group: ketamine 2 mg/kg iv as induction agent etomidate group: etomidate 0.2 mg/kg iv as induction agent

Eligibility

Sex/Gender
ALL
Age
19 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* age 19\ 70 * Shock index ≥ 0.9 * Patients who need intubation regarding to Ajou trauma center protocol

Exclusion criteria

* during CPR * CPR before hospital arrival * Severe head trauma * Steroid intake history

Design outcomes

Primary

MeasureTime frameDescription
Systolic blood pressure difference compared with baseline after 10 minutes13 minutesSystolic blood pressure 10 minutes after induction agent injection - baseline systolic blood pressure mmHg Positive or zero value means good result. Negative value means poor result.

Secondary

MeasureTime frameDescription
Intubating condition5 minutesIntubator judge intubating condition Laryngoscopy: easy / fair / difficult (difficult is the worst result) Vocal cords position: abducted / moving / closed (closed is the worst result) Reaction to insertion of the tracheal tube and cuff inflation : none / slight / vigorous (none is the worst result) If one of category checked the worst score, it considered :clinically unacceptable.
Incidence of hypotension25 minutesIf any of these are checked, define as hypotension (from injection of induction agent to 20 minutes after) 1. systolic pressure \< 90 mmHg 2. systolic pressure decrease \> 40% compared to baseline 3. Initiation of vasopressor 4. Vasopressor dose increase \> 30% of initial vaopressor dose 5. Fluid or blood loading Patient numbers (%)
Incidence of hypertension25 miinutesFrom injection of induction agent to 20 minutes after, systolic pressure \> 160 mmHg defined as hypertension Patients numbers (%)

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026